Asthmais acomplicated condition with a number of causes.
Also, you could monitor your condition and follow a detailed action plan to keep asthma symptoms at bay.
These types of inhalers serve as fast-acting treatments for acute symptoms.
PixelsEffect / Getty Images
But people with more severe asthma will likely have aninhaled steroid.
These inhalers provide powerful anti-inflammatory treatment for asthma control.
Some people have trouble using an inhaler properly and don’t get the medicine where it needs to go.
Aspacer(a holding chamber between your inhaler and mouth) can help reduce these problems.
Talk to your healthcare provider.
They can help you manage uncomfortable side effects or make changes in your medication if necessary.
you might share this information with your healthcare provider to fine-tune your treatment.
Understand Asthma Control
Those with asthma often ignore or minimize symptoms.
Nearly three of four people with asthma wake in the middle of the night at least once per week.
And 40% of asthma patients have nighttime symptoms every night.
Your healthcare provider develops the plan with your input to help you gain control of your condition.
Choose Pets Wisely
Allowing your pet to sleep with you might lead to poorly controlled asthma.
It’s a common reason asthma patients fail to get their asthma under good control.
Every year, you spend many hours in your bedroom.
And dander from your pet triggers theprocess of asthma.
While this seems obvious, many people don’t consistently take their medications.
Sometimes, people begin to feel better and have fewer symptoms, then stop using their controller medications regularly.
Asthma never really goes away, despite your improved symptoms.
Part of that comes from monitoring and understanding your symptoms, triggers, and medications.
American Lung Association.Measuring your peak flow rate.
2014;27(2):79-82. doi:10.1080/08998280.2014.11929063
Asthma and Allergy Foundation of America.Asthma action plan.
Lockey RF.The myth of hypoallergenic dogs (and cats).J Allergy Clin Immunol.
2012;130(4):910-1. doi:10.1016/j.jaci.2012.08.019
